Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT03834857
Registration number
NCT03834857
Ethics application status
Date submitted
1/02/2019
Date registered
8/02/2019
Date last updated
1/09/2022
Titles & IDs
Public title
SWITCH: Stentrode First-in-Human Study of Implantable BCI for Control of a Digital Device
Query!
Scientific title
Stentrode With Thought-controlled Digital Switch: An Early Feasibility Study (EFS) of the Safety of the Stentrode Device in Participants With Loss of Motor Function Due to Paralysis
Query!
Secondary ID [1]
0
0
S-01-01
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Neurologic Disorder
0
0
Query!
Condition category
Condition code
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Devices - Stentrode
Other: single - Implantation of Stentrode device
Treatment: Devices: Stentrode
Implantation of Stentrode device
Query!
Intervention code [1]
0
0
Treatment: Devices
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Treatment-Related Adverse Events
Query!
Assessment method [1]
0
0
Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0
Query!
Timepoint [1]
0
0
12 month post implant
Query!
Secondary outcome [1]
0
0
High fidelity and stable signals over 12 months
Query!
Assessment method [1]
0
0
The mean and standard deviation (SD) of first three measurements of impedance values across all 16 channels, excluding flag values, to a maximum of 10 measurements
The mean and SD of noise floor calculated from 2 mins of baseline recording
The mean and SD of signal-to-noise ratio across 3 mins recording of photic stimulation
Query!
Timepoint [1]
0
0
36 months
Query!
Eligibility
Key inclusion criteria
1. Clinical diagnosis of spinal cord injury (SCI), motor neurone disease (MND) [also
known as amyotrophic lateral sclerosis (ALS)], stroke, muscular dystrophy or loss of
limbs.
2. Diagnosed for at least six (6) months and if SCI, at least twelve (12) months
3. Aged between 18 and 75 years of age; females must be of non-child bearing potential or
with negative pregnancy test and not breast feeding
4. Life expectancy of at least twelve (12) months in the opinion of the treating
physician
5. Understands English
6. Is computer literate
7. Is willing and able to access all clinical testing locations and is not impeded by
geographical location (ie: ideally lives within 100 kms or Less than 2 hours travel
time to study site)
8. No conditions, including an eye movement disorder, that would prevent the use of eye
tracking software and has a level of vision that will not impede viewing of screens
and visualisations
9. Has normal venous sinus anatomy, with two patent jugular veins (of sufficient size for
the device) and bilateral patent transverse sinuses as evidenced by MR venography
(MRV) or CT venography (CTV) within the last six (6) months or if vascular anatomy is
unknown, is willing to undergo an MRV or CTV assessment to assess vascular suitability
for endovascular device placement
10. Evidence of activation, under fMRI testing, of motor cortical areas adjacent to the
superior sagittal sinus
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
75
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1. Is unwilling to comply with all procedures relating to study
2. Based on the doctors opinion, has unrealistic expectations regarding the possible
benefits, risks and limitations associated with the implantation or surgical
procedures
3. Has dementia or cognitive impairment sufficient to impair capacity to provide informed
consent or which could impact ability to comply with investigational requirements (eg:
MMSE <24, ECAS or other determination made by Investigator)
4. For MND participants, has NOT had a formal capacity assessment by a professional with
experience in capacity assessment (psychiatrist, neurologist, psychologist) within 90
days of Screen1 visit, which assesses capacity to consent and excludes Frontotemporal
dementia
5. Has a history of substance abuse within the preceding two (2) years
6. Chronic oral or intravenous steroids or immunosuppressive therapy or other
therapy/clinical condition that severely reduces immunity Has been hospitalized for a
psychiatric condition with the preceding two (2) years or has had a history of
psychosis within the preceding two (2) years
7. Has a contraindication to magnetic resonance imaging (MRI)
8. Has an active implanted stimulation device (eg: pacemaker, deep brain stimulator,
spinal cord stimulator)
9. Is deemed unsuitable by a specialist anaesthesiologist or respiratory physician to
undergo a general anaesthetic
10. Has findings on MRV deemed incompatible, by an experienced neurointerventionalist,
with device implantation in the SSS [eg: isolated dominant, superior anastomotic vein
(vein of Trolard)]
11. Has a contraindication to angiographic imaging, including chronic kidney injury (CKI
-eGFR < 60mls/min)
12. Has known allergy to contrast media
13. Has any bleeding disorders (tests required if clinical status unknown) or is resistant
to aspirin and/or clopidogrel or has any contraindication that precludes
antithrombotic treatment
14. Has an allergy to any materials included in the implanted device
15. Has a history of Deep Vein Thrombosis (DVT) or on hormone therapy (eg: HRT)
16. Any serious disease or disorder that in the opinion of the Investigator, could
seriously affect ability to participate in the study
17. Does not have a family member/caregiver (or equivalent) who can be present during the
consent process and support all study visits
18. Has had any of the following neuropathologies;
1. Sinus Thrombosis
2. Venous Hypertension
3. Hydrocephalus
4. Bleeding Disorders
Query!
Study design
Purpose of the study
Device Feasibility
Query!
Allocation to intervention
N/A
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
27/05/2019
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
9/01/2022
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
5
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
0
0
Royal Melbourne Hospital - Melbourne
Query!
Recruitment postcode(s) [1]
0
0
3050 - Melbourne
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
Synchron Australia Pty Ltd.
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
SWITCH Study
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT03834857
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Thomas Oxley
Query!
Address
0
0
University of Melbourne and Synchron
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT03834857
Download to PDF